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Abstract: Porous calcium phosphate (CaP) materials as bone graft substitutes can be prepared from
Ca carbonate biomineral structures by hydrothermal conversion into pseudomorphic CaP scaffolds.
The present study aims at furnishing such phosphatized Ca carbonate biomineral (PCCB) materials
with antibacterial Ag ions in order to avoid perisurgical wound infections. Prior to this study, PCCB
materials with Mg and/or Sr ions incorporated for stimulating bone formation were prepared from
coral skeletons and sea urchin spines as starting materials. The porous PCCB materials were treated
with aqueous solutions of Ag nitrate with concentrations of 10 or 100 mmol/L, resulting in the
formation of Ag phosphate nanoparticles on the sample surfaces through a replacement reaction.
The materials were characterized using scanning electron microscopy (SEM) energy-dispersive
X-ray spectroscopy (EDS) and X-ray diffractometry (XRD). In contact with Ringer‘s solution, the Ag
phosphate nanoparticles dissolved and released Ag ions with concentrations up to 0.51 mg/L, as
shown by atomic absorption spectroscopy (AAS) analyses. In tests against Pseudomonas aeruginosa
and Staphylococcus aureus on agar plates, antibacterial properties were similar for both types of
Ag-modified PCCB materials. Concerning the antibacterial performance, the treatment with AgNO3
solutions with 10 mmol/L was almost as effective as with 100 mmol/L.
Keywords: bone graft substitute materials; porous calcium phosphate; coralline hydroxyapatite;
phosphatized sea urchin spines; resorbable implant materials; bioactive implant materials;
antibacterial properties; magnesium; strontium; silver
1. Introduction
Bone graft procedures are common surgical operations exceeding an annual number of two
million interventions [1]. Synthetic materials as bone graft substitutes can be used to avoid drawbacks
of autografts, such as additional blood loss, pain and risk of infection at the donor site [2–4]. Substitute
materials based on CaP closely resemble human bone in composition and properties [5,6], show
excellent biocompatibility and integrate well with the bone tissue [7,8]. Interconnected macropores in
the implant material enhance bone regeneration and, thereby, promote the fixation of the implant [9–16].
Ideally, such an implant should actively stimulate bone formation to accelerate the osteointegration
and, after stabilizing the filled defect, the implant material should become resorbed in the natural
process of bone remodeling [17].
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Despite their compositional similarity to bone, results of pure hydroxyapatite [HA, Ca5(PO4)3OH]
implants were unsatisfactory, because they did not induce bone formation [18–22] and were hardly
resorbable [23]. Implants of pure β-tricalcium phosphate [β-TCP, Ca3(PO4)2] with bone marrow
aspirate gave better results than HA materials [21], but β-TCP was resorbed rather too fast, leaving
the implant site mechanically unstable [24,25]. However, using mixtures of different CaP phases,
degradation rates can be adjusted to the rate of new bone formation [26].
Among other CaP implant materials, PCCBs represent one group of materials that can be used
as bone graft substitutes. Phosphatized Ca carbonate biomineral materials are based mainly of
biominerals with natural macroporosity that are pseudomorphically converted into CaP materials
by a coupled dissolution and precipitation process in hydrothermal phosphate solution, during
which the porosity is preserved [27–30]. The most common PCCBs in clinical use are derived from
coral skeletons (originally consisting of aragonite, CaCO3) that are converted into HA (often termed
“coralline HA”) [31]. However, these materials were criticized for their lack of resorbability [32]. As a
promising alternative, PCCB derived from sea urchin spines (originally consisting of calcite, CaCO3,
with Ca ions partially substituted by Mg ions) have been tested as bone implants [29]. The substantial
amounts of Mg in the reaction system shifted the phase equilibrium from HA toward the resorbable
Mg- and carbonate-substituted β-TCP of which the phosphatized material mainly consisted [29,30].
Resorbable implant materials that contain Mg and Sr ions support the formation of bone and, therefore,
can be considered bioactive: Mg-containing CaP enhance the adhesion, proliferation and metabolic
activity of osteoblast-like cells [33]. Strontium ions stimulate the formation of bone by enhancing the
osteogenic differentiation of mesenchymal stem cells [34] and additionally counteract bone loss as in
osteoporosis by inhibiting bone resorption [35,36].
Many studies have been conducted on Ag-modified CaP implant materials, aiming at a
decrease of the perisurgical risk of wound infections. Antibacterial properties of Ag ions have
been demonstrated in studies on various materials: HA powders [37–40], HA coatings [41–45],
HA ceramics [46,47], coralline HA [30,48], β-TCP materials [30,49,50], and mixed phase CaP
ceramics [51,52]. The antimicrobial effect is directly related to the release of Ag ions which inhibit
the proper functioning of the bacterial ribosome [53] and have an adverse effect on bacterial DNA
replication [54]. In moderate concentrations, Ag ions can be antimicrobially effective without impairing
the cytocompatibility [47,55]. Generally, microbial growth is inhibited in the presence of metallic,
colloidal or ionic Ag [30,56,57].
Part I of the present study was aimed at developing coral and sea urchin-derived PCCB towards
resorbable, bioactive and antiosteoporotic bone graft substitute materials by the incorporation of Mg
and/or Sr ions [58]. Part II, presented here, is a feasibility study dedicated to endowing the resulting
materials with antibacterial properties by adding Ag ion-releasing nanoparticles to the material
surfaces. It was intended to investigate the replacement reaction system of Mg- and/or Sr-modified
porous PCCB in Ag nitrate solutions for the composition and distribution of the Ag-containing phases
produced as well as their properties in releasing Ag ions upon dissolution in Ringer’s solution and
their antibacterial effectiveness, respectively.
2. Results and Discussion
2.1. Modification with Silver Ions
The coral-derived starting material consisted of Na- and Sr-doped HA combined with
Sr-substituted β-TCP [(Ca,Sr)3(PO4)2] as a surface layer and some aragonite. The sea urchin-derived
starting material was composed of merrillite (Na-Mg-substituted β-TCP; Ca9NaMg(PO4)7) with some
additional Sr as the dominant phase, HA as a secondary phase and some Mg-calcite.
Phosphatized and Mg and/or Sr-modified materials were treated with Ag nitrate solutions
with concentrations of either 10 mmol/L (sample codes C Ag 10 for coral- and SU Ag 10 for sea
urchin-derived materials) or 100 mmol/L (sample codes C Ag 100 for coral- and SU Ag 100 for sea
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urchin-derived materials). This treatment did not affect the porous structure of the materials as visible
for the coral-derived material in Figure 1a. The reaction resulted in the precipitation of nanoparticles
evenly dispersed at the surfaces of the samples (Figure 1b and inset). Here, the difference between the
samples C Ag 100 (Figure 1) and C Ag 10 consisted in a much lower density of particles in the latter
case (Figure S1). Element analyses with environmental scanning electron microscopy (ESEM)-based
energy-dispersive X-ray spectroscopy (EDS) were done at fractured trabeculae in steps of 10 µm from
the surface to the center (Figure 1c–f). Energy-dispersive X-ray spectroscopy analyses indicated that the
pseudomorphic phosphate phase contained a constant concentration of C (Figure 1c–e). Since in this
case the sample was not coated with carbon, this C content may represent carbonate ions originating
from dissolution of aragonite and reprecipitating as substituents in the newly formed CaP phase.
However, the analyzed carbon content could also represent carbon from the atmosphere fixed on the
sample surface. Nevertheless, an incorporation of some carbonate into the pseudomorphic CaP phases
has to be expected for all described experiments of phosphatization. At the center of trabecula, some
original aragonite persisted as indicated by the higher carbon content (Figure 1f; mixed analysis of
original aragonite and pseudomorphic phosphate material). At the surface, substantial concentrations
of Ag were detected (Figure 1c), which can be correlated with the nanoparticles visible in Figure 1b.
Even below the surface, Ag was detected with lower concentrations in the internal phosphate material
(Figure 1d–f). Determination of the crystalline phases in the material by means of XRD yielded a
residue of the original aragonite, HA as the predominant pseudomorphic phase, small amounts
of Sr-β-TCP, c.f. [59] (probably the main phase at the surfaces), and Ag phosphate (Ag3PO4; PDF
00-006-0505) (Figure 1g).
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Figure 1. Phosphatized and Sr-modified coral skeleton with additional Ag functionalization (sample 
C Ag 100). (a) Porous structure of the material (environmental scanning electron 
microscopy-backscatter electron (ESEM-BSE)); (b) a fractured trabecula (fracture edge indicated) 
showing the internal microstructure of the material on the right hand side (darker shading; center of 
trabecula indicated) and the material surface (indicated) with a layer of small crystals composed of 
heavier elements (lighter shading) on the left hand side and dispersed nanocrystals composed of 
heavy elements (white dots; see inset) (ESEM-BSE). Energy-dispersive X-ray spectroscopy analyses 
show the chemical composition at (c) the surface and of the interior of the material at depths of (d) 10 
µm, (e) 20 µm, and (f) 30 µm. (g) Crystalline phases contained in the material, identified by XRD 
(aragonite PDF 00-041-1475, hydroxyapatite PDF 00-009-0432, Sr-β-TCP, c.f. [59], Ag phosphate PDF 
00-006-0505); XRD raw data S1: C33. 
In the case of sea urchin-derived phosphatized and Sr-modified material, treatment with Ag 
nitrate solution did not affect the porous morphology of the sample (Figure 2a) but resulted in 
nanoparticles dispersed at the sample surface (Figure 2b), similar to those of coral-derived material. 
Correspondingly, Ag was detected at the surface of the sample (Figure 2c) and also in the bulk 
material (Figure 2d). Larger specimens of the surface crystals displayed distinct cubic morphologies 
(Figure 2e) and were shown to contain high concentrations of Ag (Figure 2f). Beside Ag, Sr, Mg, and 
Na, the CaP material contained some C as well (Figure 2c,d). This C content probably represents at 
least partly carbonate ions dissolved from the sea urchin calcite along with the Ca and Mg ions, 
i Sr- odified coral skeleton with ad it onal Ag functionalization (sample C
Ag 100). (a) Porous structure of the mat rial (environ ental scanning electron microscopy-backs atter
ele tron (ESEM-BSE)); (b) a fractured trabecula (fracture ge indicated) showing the internal
microstructure of the aterial on the right hand side (darker shading; center of t abecula indicated)
and the materi l surface (indicated) with a layer of small cryst ls composed of heavier elements
(light shadi g) on th left ha d side and dispersed nanocrystals composed of heavy elements
(white dots; see inset) (ESEM-BSE). Energy-dispersive X-ray spectro copy analyses sh w the chemical
composition at (c) the surface and of the interior of the material at depths of (d) 10 µm, (e) 20 µm,
and (f) 30 µm. (g) Crystalline phases contained in the material, identified by XRD (aragonite PDF
00-041-1475, hydroxyapatite PDF 00-009-0432, Sr-β-TCP, c.f. [59], Ag phosphate PDF 00-006-0505); XRD
raw data S1: C33.
In the case of sea urchin-derived phosphatized and Sr-modified material, treatment with Ag
nitrate solution did not affect the porous morphology of the sample (Figure 2a) but resulted in
nanoparticles dispersed at the sample surface (Figure 2b), similar to those of coral-derived material.
Correspondingly, Ag was detected at the surface of the sample (Figure 2c) and also in the bulk material
(Figure 2d). Larger specimens of the surface crystals displayed distinct cubic morphologies (Figure 2e)
and were shown to contain high concentrations of Ag (Figure 2f). Beside Ag, Sr, Mg, and Na, the CaP
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material contained some C as well (Figure 2c,d). This C content probably represents at least partly
carbonate ions dissolved from the sea urchin calcite along with the Ca and Mg ions, which subsequently
reprecipitated as substituted CaP. Here as well, the detected carbon may also represent carbon from
the atmosphere fixed on the sample surface. In addition to the crystalline phases of the material before
Ag functionalization took place (Mg-calcite, merrillite, and HA), the XRD pattern shows distinct peaks
of Ag phosphate (Figure 2g), which corresponds to the crystals with cubic morphology in Figure 2e
and the chemical composition shown in Figure 2f.
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Figure 2. Phosphatized and Sr-modified sea urchin spine with additional Ag functionalization 
(sample SU Ag 100). (a) Porous structure of the material (ESEM-BSE); (b) a fractured trabecula 
showing the internal microstructure of the material and rose-shaped aggregates of crystals grown on 
the surface with additional microcrystals composed of heavy elements dispersed on the surface 
(white dots; ESEM-BSE). Energy-dispersive X-ray spectroscopy analyses show the chemical 
composition of (c) the surface material and (d) the bulk material. (e) Cubic microcrystals on the 
material’s surface. (f) chemical composition of these microcrystals (EDS). (g) Mineral phases 
contained in the material, identified by XRD (Mg-calcite PDF 00-043-0697, merrillite PDF 
01-076-8368, hydroxyapatite PDF 00-009-0432, and Ag phosphate PDF 00-006-0505); XRD raw data 
S2: SU25. 
Treating the Sr-modified phosphate materials with an aqueous solution of Ag nitrate produced 
Ag phosphate at the surfaces, the vast majority in the form of nanoparticles, but interspersed with 
some microparticles. The reason for the growth of these few larger particles could not be identified. 
The precipitation of Ag phosphate was coupled with the dissolution of Sr-β-TCP or Sr-merrillite, 
respectively, according to the following simplified reactions: 
Ca3Sr3(PO4)4 + 12 Ag+ ⟹ 4 Ag3PO4 + 3 Ca2+ + 3 Sr2+ (1) 
or 
Ca8NaMgSr(PO4)7 + 21 Ag+ ⟹ 7 Ag3PO4 + 8 Ca2+ + Na+ + Mg2+ + Sr2+ (2) 
Compared to their small volume, nanoparticles have large surface areas at which reactions with 
fluid environments can take place. Therefore, the small size of Ag phosphate particles and their even 
distribution at the surfaces are promising material properties for rapid and spatially uniform 
dissolution and release of Ag ions upon application. In another study on coralline HA as potential 
bone implant material, a similar approach was found to be viable for an effective antibacterial 
Ag-modification of the material [48]. 
2.2. Release of Silver Ions upon Dissolution 
The antibacterial effect of Ag in bone graft substitute materials is assumed to be based mainly 
on the release of Ag ions upon dissolution of Ag-containing compounds in the surrounding body 
fluid, which starts after the implant surgery. In an experimental approach to this process, coral- and 
sea urchin-derived samples with Ag-functionalization (samples C Ag 100 and SU Ag 100) were held 
in Ringer’s solution at body temperature. The aim of these experiments was to demonstrate that Ag 
ions actually become released from these materials and to determine the concentration range for Ag 
ions in solution. For comparison, samples of Ag phosphate and Ag chloride were treated in the same 
way, because these were the relevant Ag compounds in the reaction systems. The solutions resulting 
from these experiments as well as a sample of the pristine solvent (sample Ringer) were analyzed 
using atomic absorption spectroscopy (AAS) (Table 1). For coral- and sea urchin-derived materials, 
concentrations of dissolved Ag ions were found to be in the range of 0.45 to 0.51 mg/L. The 
solubilities of Ag phosphate and Ag chloride in Ringer’s solution were both found to be in a similar 
range, while Ringer’s solution itself contained only negligible concentrations of Ag ions. The 
2. Phosphatized and Sr-modified sea urchin spi e with additional Ag functionalizati (sample
SU Ag 100). (a) Porous structure of the material (ESEM-BSE); (b) a fractured trabecula showing the
internal microstructure of the material and ros -shape aggreg tes of cryst ls grown on the surface
with additional microcrystals composed of heavy elements disp rsed on the surface (white dots;
ESEM-BSE). Energy-dispersive X-ray spectroscopy analyses show the chemical composition of (c) the
surface material and (d) the bulk aterial. (e) Cubic microcrystals on the material’s surface. (f) chemical
composition of these microcrystals (EDS). (g) Mineral phases contained in the material, identified by
XRD (Mg-calcite PDF 00-043-0697, merrillite PDF 01-076-8368, hydroxyapatite PDF 00-009-0432, and
Ag phosphate PDF 00-006-0505); XRD raw data S2: SU25.
Treating the Sr-modified phosphate materials with an aqueous solution of Ag nitrate produced
Ag phosphate at the surfaces, the vast majority in the form of nanoparticles, but interspersed with
some microparticles. The reason for the growth of these few larger particles could not be identified.
The precipitation of Ag phosphate was coupled with the dissolution of Sr-β-TCP or Sr-merrillite,
respectively, according to the following simplified reactions:
Ca3Sr3(PO4)4 + 12 Ag+ ⇒ 4 Ag3PO4 + 3 Ca2+ + 3 Sr2+ (1)
or
Ca8NaMgSr(PO4)7 + 21 Ag+ ⇒ 7 Ag3PO4 + 8 Ca2+ + Na+ + Mg2+ + Sr2+ (2)
Compared to their small volume, nanoparticles have large surface areas at which reactions
with fluid environments can take place. Therefore, the small size of Ag phosp ate particles and
their even distributio at the surfaces are promising material properties for rapid and spatially
uniform dissolution and release of Ag ions upon application. In another study on coralline HA as
potential bone implant material, a similar approach was fou d to be viable for an effective antibacterial
Ag-modification of the material [48].
2.2. Release of Silver Ions upon Dissolution
The antibacterial effect of Ag in bone graft substitute materials is assumed to be based mainly
on the r lease of Ag ions up n dissolution of Ag-containing compound in the surrounding bod
fluid, which starts after the implant surgery. In an exper mental ap roach to this process, coral- and
sea urchin-derived samples with Ag-functionalization (sa ples C Ag 100 and SU Ag 100) were hel
in Ringer’s solution t body temperat re. The aim of these experiments w s to demonstrate that Ag
ons actually become released from thes materials and to determin the concentrati range for
in solution. For comparison, samples of Ag phosphate and Ag chloride w re treated i the same
way, because these were the relevant Ag c mpounds in th reaction systems. Th solutions resulting
from these experiments as w ll as a sample of the pristin solvent (sample Ringer) were analyzed
using atomic absorption spectroscopy (AAS) (Table 1). For coral- and sea urchi -deriv d materials,
concentrations of dissolved Ag i ns were found to in the ange of 0.45 to 0.51 mg/L. The solubilities
of Ag phosphate an Ag chloride in Ring ’s s lution were bot found to be in a similar ran e, whil
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Ringer’s solution itself contained only negligible concentrations of Ag ions. The concentrations found
for the Ag ions did not clearly show dependence of the reaction time (24 h or 72 h) with Ringer’s
solution, which presumably indicated that the solutions were already nearly saturated with respect to
the relevant substances within 24 h. Non-systematic variations in the solubility or dissolution rates
may be caused by differences in the materials’ crystallinity or particle sizes.
Table 1. Silver ion concentrations determined with atomic absorption spectroscopy (AAS) after material
dissolution in Ringer’s solution at 37 ◦C for 24 h and 72 h.
Sample Reaction Time Ag+ (mg/L)
C Ag 100 24 h 0.45
C Ag 100 72 h 0.51
SU Ag 100 24 h 0.51
SU Ag 100 72 h 0.47
Ag3PO4 24 h 0.49
Ag3PO4 72 h 0.59
AgCl 24 h 0.46
AgCl 72 h 0.46
Ringer ——– 0.06
The incorporation of Ag ions into the materials was intended to provide the materials with
antibacterial properties upon implantation. The narrow range of Ag ion concentrations released into
Ringer’s solution by all samples, largely independent of the reaction time after 24 h (Table 1), reflect fast
initial dissolution kinetics of the Ag phosphate nanoparticles at the material surfaces. This dissolution
process is coupled with reprecipitation of Ag ions as Ag chloride, which is the least soluble salt of Ag
in this environment. Therefore, the concentration of dissolved Ag ions is limited by the solubility of
Ag chloride. According to a thermodynamic calculation with Visual MINTEQ 3.1 [60], the theoretical
solubility of Ag chloride in Ringer’s solution at 37 ◦C is 12.72 µmol/L, equaling a weight-based
concentration of Ag ions of about 1.37 mg/L. In simulated serum electrolyte solution, the maximum
concentration of Ag ions is even lower at about 0.15 mg/L [61]. These measured and calculated values
suggest that dissolution of Ag salts in chloride-containing solutions will usually produce Ag ion
concentrations exceeding the threshold for antibacterial effectiveness (≥0.1 mg/L) but staying below
cytotoxic levels (≥1.6 mg/L) [55]. Nevertheless, upon implantation, all Ag salts present will become
completely dissolved in serum over time, because the surrounding tissue and body fluid represent a
semi-open system in which dissolved species disperse and hence become diluted continuously. In this
system, gradual dissolution of Ag salts and dispersion of Ag ions are additionally promoted by serum
proteins which sequester these ions [61], acting as a mobile temporary sink for Ag ions and facilitate
their dispersion. The total amount of Ag ions in implants should, however, be limited to the minimum
required for antibacterial effectiveness, because finally they tend to accumulate in the liver and other
organs and may impair their functions [61].
2.3. Antibacterial Tests
Antibacterial properties of Ag-functionalized samples were determined by means of inhibition of
two different bacterial strains, Pseudomonas aeruginosa and Staphylococcus aureus. Bacterial inhibition
was expected as an effect of Ag ions which dissolved from the samples and diffused through the
agar gel substrate. In these experiments, the width of the area of inhibition served as a measure of
antibacterial effectiveness.
As expected, all Ag-functionalized samples clearly showed antibacterial properties. In the case of
Gram-negative P. aeruginosa, the area of inhibition was about 1.1–1.2 mm wide with C Ag 10 and SU
Ag 10 samples being insignificantly less effective than C Ag 100 and SU Ag 100 samples (Figure 3a–c).
Gram-positive S. aureus was more sensitive to Ag ions. Here, C Ag 10 and SU Ag 10 samples effected
inhibition areas with widths of about 3 mm, while C Ag 100 and SU Ag 100 samples were slightly
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more effective with about 4 mm width of the inhibition areas (Figure 3d–f). Generally, coral- and sea
urchin-derived materials with corresponding Ag ion-treatment did not show significant differences in
their antibiotic effectiveness. Ag-free control samples C Ag 0 and SU Ag 0 with no antibacterial effect
clearly indicate that the antibacterial properties of C Ag 10 and SU Ag 10 samples as well as those
of C Ag 100 and SU Ag 100 samples are based on their Ag content and not on other components of
the samples.
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antibacterial effect of Ag ions than P. aeruginosa. This finding of differential sensitivity is in 
accordance with the finding of Schlosser et al. [30] and was also observed in corresponding 
experiments with the antibiotic ampicillin (Figure S2). The higher level of resistance of P. aeruginosa 
is based on the presence of an additional outer membrane in Gram-negative bacteria [62]. In 
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Figure 3. Antibacterial effects of phosphatized and Sr-modified materials with and without additional
Ag functionalization on bacterial strains of Pseudomonas aeruginosa (Gram-negative) and Staphylococcus
aureus (Gram-positive). Pseudomonas aeruginosa-seeded agar plates inoculated with (a) coral-derived
materials and (b) sea urchin-derived materials and (c) measurements (with standard deviations) of the
lateral bacterial inhibition areas for the different materials. Staphylococcus aureus-seeded agar plates
inoculated with (d) coral-derived materials and (e) sea urchin-derived materials and (f) measurements
(with standard deviations) of the lateral bacterial inhibition areas for the different materials. (C Ag
0 and SU Ag 0: no treatment with Ag ions; C Ag 10 and SU Ag 10: treated with 10 mM Ag solution;
C Ag 100 and SU Ag 100: treated with 100 mM Ag solution.)
As demonstrated by the results of the dissolution experiments (Table 1), Ag phosphate particles
dissolve in a physiological fluid and release Ag ions. The antibacterial tests presented here are
based on the dispersion of released Ag ions in the surrounding agar medium by diffusive transport.
The maximum distance at which an inhibition of bacterial growth was observed (i.e., the diffusion
front with a minimum concentration of Ag ions for an antibacterial effect) was used as a measure of
the antibacterial effectiveness. This approach was already chosen in earlier studies [30,48]. In our
antibacterial tests, the larger areas of inhibition for Gram-positive S. aureus suggest lower concentrations
of Ag ions to be sufficient in this case compared to P. aeruginosa (Gram-negative) exhibiting smaller
inhibition areas. In turn, it follows that S. aureus is more sensitive to the antibacterial effect of Ag
ions than P. aeruginosa. This finding of differential sensitivity is in accordance with the finding of
Schlosser et al. [30] and was also observed in corresponding experiments with the antibiotic ampicillin
(Figure S2). The higher level of resistance of P. aeruginosa is based on the presence of an additional
outer membrane in Gram-negative bacteria [62]. In Ag-based inhibition experiments, the samples with
lower contents of Ag phosphate (C Ag 10 and SU Ag 10) were generally equally or nearly as effective
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against bacterial growth as samples with considerably higher Ag contents (C Ag 100 and SU Ag 100).
This finding agrees with observations by Zhang et al. [48] and may suggest the resource-conserving use
of lower concentrated Ag nitrate (10 mmol/L) solution during antibacterial functionalization, which
also reduces the total load of potentially adverse Ag ions introduced to the organism. Small amounts
of surface-attached Ag phosphate releasing Ag ions over a time period of only a few days should be
sufficient for the desired antibacterial effect, because an acute risk of infection exists mainly during
the surgery and shortly thereafter. Hence, a long-term antibacterial functionality is not necessary.
With regard to a possible future application as implant materials, however, it seems difficult to estimate
the amount of Ag phosphate necessary to ensure the persistence of a sufficient reservoir for Ag ions
over a period of a few days. Trials with more realistic model systems would be mandatory.
3. Materials and Methods
3.1. Starting Materials
The starting materials for the present study were prepared and characterized during previous
research work [58]: A coral skeleton (Porites sp., aragonite, CaCO3) and a sea urchin spine
(Heterocentrotus mamillatus, Mg-calcite, Ca9Mg(CO3)10) were cut to produce samples of about 0.5
to 0.7 g. These samples were cleaned of organic material with hydrogen peroxide solution (H2O2
10%) and subjected to hydrothermal treatment with an aqueous solution of Na2EDTA · H2O
(0.2 mol/L, ethylenediaminetetraacetic acid disodium salt dihydrate), SrCl2 · 6 H2O (0.1 mol/L), and
Na2HPO4 · 2 H2O (1.0 mol/L). Each sample was placed in 35 mL solution in a TeflonTM-lined autoclave
(steel bomb, 125 mL volume; Parr Instrument, Frankfurt, Germany) and held at 200 ◦C for 168 h. The
porous Ca carbonate biominerals were partially converted into pseudomorphic PCCB via a coupled
dissolution and precipitation mechanism with additional Na and Sr ions from the solution incorporated
in the CaP phases. The phosphatized sea urchin material also contained substantial concentrations of
Mg ions that were reprecipitated together with the Ca ions after Mg-calcite dissolution. At the start
of the present study, the coral-derived material consisted of microcrystalline, Na- and Sr-doped HA
with a surface layer of Sr-substituted β-TCP [(Ca,Sr)3(PO4)2] beside residual aragonite. In the case
of the sea urchin-derived material, the Mg ions induced a shift towards the formation of merrillite
(Na-Mg-substituted β-TCP; Ca9NaMg(PO4)7) with an additional Sr content as the dominant phase,
while HA occurred as a secondary but still significant phase beside residual Mg-calcite. The surfaces of
the sea urchin-derived material were studded with rose-shaped crystal aggregates probably consisting
of Sr-substituted β-TCP.
3.2. Treatment with Silver Ions
The samples were held in aqueous solutions of AgNO3 (10 mmol/L or 100 mmol/L) at 25 ◦C for
24 h (sample codes in Figure 3: C Ag 10 and C Ag 100 for coral materials; SU Ag 10 and SU Ag 100 for
sea urchin materials). Afterwards, they were thoroughly washed in deionized water and dried using a
tissue that absorbed the pore fluid to avoid precipitation due to evaporation. The entire treatment,
storage and characterization of these samples were performed under ruby light or at low light intensity,
because a light-sensitive phase was expected to precipitate during the interface reaction.
3.3. Sample Characterization
The samples were cleaved to expose fresh fracture surfaces of the material before mounting the
samples on aluminum stubs with carbon tabs for characterization with scanning electron microscopy
(SEM; FEI ESEM Quanta 200 FEG, ThermoFisher Scientific, Hillsboro, OR, USA) at 12.5 kV accelerating
voltage. The Ag-modified samples remained uncoated, because the light-emitting carbon-coating
process would possibly alter light-sensitive phase in samples. Hence, the SEM was operated in
low-vacuum mode with an atmosphere of 1.3 mbar water vapor in the sample chamber (environmental
scanning electron microscopy, ESEM), which provided electron conductivity at the cost of slightly
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reduced image resolution. The morphologies of the samples and material contrasts were imaged
in backscatter electron (BSE) imaging mode. Additionally, the chemical compositions of the sample
materials were determined using SEM-integrated energy-dispersive X-ray spectroscopy (EDS; EDAX,
Mahwah, NJ, USA). Here, the uncoated samples allowed for unbiased analyses of the carbon contents.
For identification of the crystalline phases, selected samples were powdered in an agate mortar
prior to applying X-ray diffraction (XRD; D8, Bruker, Billerica, MA, USA) in Bragg–Brentano geometry
using CuKα radiation. Sample C Ag 100 was consistent with XRD sample C33 (XRD raw data S1),
while sample SU Ag 100 was consistent with XRD sample SU25 (XRD raw data S2).
3.4. Cation Release upon Dissolution
The release of Ag ions upon the reaction of the samples with Ringer’s solution (an aqueous
solution containing NaCl (8.6 g/L), KCl (0.3 g/L), and CaCl2 · 2 H2O (0.33 g/L) at pH 7.4, isotonic
in relation to body fluids), was investigated. Cleaved pieces of about 50 mg of the samples C Ag 100
and SU Ag 100 were held light-protected in 20 mL of Ringer’s solution at 37 ◦C for 24 h and 72 h,
respectively. Samples of 10 mg of AgCl and Ag3PO4, respectively, held in Ringer’s solution in the same
way as well as pure Ringer’s solution served as controls. The resulting solutions were analyzed for Ag
ions using flame atomic absorption spectroscopy (AAS; contrAA 300, Analytik Jena, Jena, Germany).
The detection limit for Ag+ was 0.02 mg/L.
3.5. Antibacterial Tests
Antibacterial properties of the Ag-modified samples were tested against two bacterial
strains relevant for wound infections, Staphyloccocus aureus DSM 1104 (Gram-positive) and
Pseudomonas aeruginosa DSM 1117 (Gram-negative). Both strains were cultivated in yeast extract
dextrose medium (YED; 5 g/L peptone, 2.5 g/L yeast extract, 1 g/L glucose, pH 7.0) at 37 ◦C and
180 rpm. Solid media were prepared with YED and agar (15 g/L), top layered with seeded soft agar
of YED with agar (10 g/L), containing a known number of bacteria (108 cfu/mL). Three different
cleaved samples of either coral- or sea urchin-derived materials were added to each agar plate for direct
comparison: two samples modified in solutions of AgNO3 and one sample without Ag-modification:
C Ag 10, C Ag 100 and C Ag 0 or SU Ag 10, SU Ag 100 and SU Ag 0 (each sample about 50 mg).
These tests were carried out in triplets for each type of materials, coral- and sea urchin-derived CaP
scaffolds, in combination with each bacterial strand, respectively (12 separate test plates in total).
As a control and for comparison, for each bacterium one plate was prepared with two filter papers
soaked with the antibiotic ampicillin (1 mg/mL and 100 mg/mL, respectively). Inoculated plates were
pre-incubated at 4 ◦C for 2 h prior to incubation at 37 ◦C for 24 h. After this incubation time, the zones
of inhibition were measured at the agar surface radially from the sample rim in five directions per
sample. From these 15 measurements per sample type (triplet), the arithmetic mean and the standard
deviation were calculated. Except for a few modifications, partly inspired by Zhang et al. [48], the
described procedure follows the protocol of Schlosser et al. [30].
4. Conclusions
In a previous study, phosphatized calcium carbonate biominerals, specifically coral- and sea
urchin-derived CaP scaffolds, were developed into porous bone graft substitute materials with
bioactive functionality through incorporation of Mg and/or Sr ions [58]. The resulting materials
were essentially triphasic, the coral material consisting of HA, Sr-substituted β-TCP, and aragonite,
while the sea urchin-derived material was composed of Sr-substituted merrillite (Na-Mg-(Sr)-β-TCP),
HA and Mg-calcite.
The present study demonstrates the treatment of these materials with Ag nitrate solutions to
precipitate Ag phosphate nanoparticles on the surfaces of the samples which, upon dissolution, release
Ag ions. Due to a self-limiting property of the reaction system in body fluid, the concentrations of
dissolved Ag ions are expected to remain in a range above the threshold for antibacterial effectiveness
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and below cytotoxicity. Therefore, the Mg- and/or Sr-modified PCCB materials, previously developed
for potential osteoinductive bioactivity, were further functionalized for reducing the risk of perisurgical
wound infections during possible future application as bone graft substitutes. The load of Ag phosphate
in the samples could be controlled by using different concentrations of Ag nitrate for the treatment
of the starting materials. In our system, samples treated with an AgNO3 solution with 10 mmol/L
showed nearly the same antibacterial performance as samples treated with 100 mmol/L. It is difficult
to estimate the optimum load of Ag3PO4 in the materials for an application as implants: on the one
hand, Ag phosphate content should provide a sufficient source for Ag ion release for an antibacterial
effect over a few days. On the other hand, the total load of Ag ions should be restricted to a minimum
to avoid health problems [61]. Trials with more realistic model systems are required optimizing the
load of Ag phosphate.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4983/9/4/67/s1,
Figure S1: Distribution of Ag phosphate nanoparticles on sample surfaces; Figure S2: Effect of ampicillin on
Pseudomonas aeruginosa and Staphylococcus aureus; XRD raw data S1: C33; XRD raw data S2: SU25.
Author Contributions: I.S. designed research, performed experiments and material characterization, validated
results, visualized data, wrote the manuscript and assisted in the acquisition of funding; S.V. designed and
performed antibacterial experiments and assisted with writing the manuscript; F.P. provided resources, suggested
methods, supervised antibacterial experiments and reviewed the original draft of the manuscript; H.-J.K. acquired
funding, provided resources, supervised the investigation and reviewed the original draft of the manuscript.
Funding: This work was supported by the German Research Foundation (DFG) (grant number KL 615/25-1).
Conflicts of Interest: The authors declare no conflict of interest. The founding sponsors had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the
decision to publish the results.
References
1. Lewandrowski, K.U.; Gresser, J.D.; Wise, D.L.; Trantolo, D.J. Bioresorbable bone graft substitutes of
different osteoconductivities: A histologic evaluation of osteointegration of poly(propylene glycol-co-fumaric
acid)-based cement implants in rats. Biomaterials 2000, 21, 757–764. [CrossRef]
2. Seiler, J.G., 3rd; Johnson, J. Iliac crest autogenous bone grafting: Donor site complications. J. South.
Orthop. Assoc. 2000, 9, 91–97. [PubMed]
3. Goulet, J.A.; Senunas, L.E.; DeSilva, G.L.; Greenfield, M. Autogenous iliac crest bone graft—Complications
and functional assessment. Clin. Orthop. Rel. Res. 1997, 339, 76–81. [CrossRef]
4. Banwart, J.C.; Asher, M.A.; Hassanein, R.S. Iliac crest bone-graft harvest donor site morbidity—A statistical
evaluation. Spine 1995, 20, 1055–1060. [CrossRef] [PubMed]
5. LeGeros, R.Z. Calcium Phophate-Based Osteoinductive Materials. Chem. Rev. 2008, 108, 4742–4753.
[CrossRef] [PubMed]
6. Dorozhkin, S.V. Bioceramics of calcium orthophosphates. Biomaterials 2010, 31, 1465–1485. [CrossRef]
[PubMed]
7. De Bruijn, J.D.; Shankar, K.; Yuan, H.; Habibovic, P. Osteoinduction and its evaluation. In Bioceramics and
Their Clinical Applications; Kokubo, T., Ed.; CRC Press: Boca Raton, FL, USA, 2008; pp. 199–219.
8. Nakamura, T.; Takemoto, M. Osteoconduction and its evaluation. In Bioceramics and Their Clinical Applications;
Kokubo, T., Ed.; CRC Press: Boca Raton, FL, USA, 2008; pp. 183–198.
9. Klawitter, J.J.; Hulbert, S.F. Application of porous ceramics for the attachment of load bearing internal
orthopedic applications. J. Biomed. Mater. Res. 1971, 5, 161–229. [CrossRef]
10. Hulbert, S.F.; Cooke, F.W.; Klawitter, J.J.; Leonard, R.B.; Sauer, B.W.; Moyle, D.D.; Skinner, H.B. Attachment of
prostheses to musculoskeletal system by tissue ingrowth and mechanical interlocking. J. Biomed. Mater. Res.
1973, 7, 1–23. [CrossRef] [PubMed]
11. Tsuruga, E.; Takita, H.; Itoh, H.; Wakisaka, Y.; Kuboki, Y. Pore size of porous hydroxyapatite as the
cell-substratum controls BMP-induced osteogenesis. J. Biochem. 1997, 121, 317–324. [CrossRef] [PubMed]
12. Hing, K.A.; Best, S.M.; Tanner, K.E.; Bonfield, W.; Revell, P.A. Quantification of bone ingrowth within
bone-derived porous hydroxyapatite implants of varying density. J. Mater. Sci.-Mater. Med. 1999, 10, 663–670.
[CrossRef] [PubMed]
J. Funct. Biomater. 2018, 9, 67 12 of 14
13. Tamai, N.; Myoui, A.; Tomita, T.; Nakase, T.; Tanaka, J.; Ochi, T.; Yoshikawa, H. Novel hydroxyapatite
ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo. J. Biomed.
Mater. Res. 2002, 59, 110–117. [CrossRef] [PubMed]
14. Hing, K.A.; Saeed, S.; Annaz, B.; Buckland, T.; Revell, P.A. Microporosity affects bioactivity of macroporous
hydroxyapatite bone graft substitutes. Key Eng. Mater. 2004, 254–256, 273–276. [CrossRef]
15. Hing, K.A. Bioceramic bone graft substitutes: Influence of porosity and chemistry. Int. J. Appl. Ceram. Technol.
2005, 2, 184–199. [CrossRef]
16. Okamoto, M.; Dohi, Y.; Ohgushi, H.; Shimaoka, H.; Ikeuchi, M.; Matsushima, A.; Yonemasu, K.; Hosoi, H.
Influence of the porosity of hydroxyapatite ceramics on in vitro and in vivo bone formation by cultured rat
bone marrow stromal cells. J. Mater. Sci. Mater. Med. 2006, 17, 327–336. [CrossRef] [PubMed]
17. Epple, M. Biomaterialien und Biomineralisation—Eine Einführung für Naturwissenschaftler, Mediziner und
Ingenieure; Teubner: Wiesbaden, Germany, 2003; 162p.
18. Chappard, D.; Zhioua, A.; Grizon, F.; Basle, M.F.; Rebel, A. Biomaterials for bone filling: Comparisons
between autograft, hydroxyapatite and one highly purified bovine xenograft. Bull. Assoc. Anat. 1993,
77, 59–65.
19. Begley, C.T.; Doherty, M.J.; Mollan, R.A.B.; Wilson, D.J. Comparative study of the osteoinductive properties
of bioceramic, coral and processed bone-graft substitutes. Biomaterials 1995, 16, 1181–1185. [CrossRef]
20. Emery, S.E.; Fuller, D.A.; Stevenson, S. Ceramic anterior spinal fusion—Biologic and biomechanical
comparison in a canine model. Spine 1996, 21, 2713–2719. [CrossRef] [PubMed]
21. Johnson, K.D.; Frierson, K.E.; Keller, T.S.; Cook, C.; Scheinberg, R.; Zerwekh, J.; Meyers, L.; Sciadini, M.F.
Porous ceramics as bone graft substitutes in long bone defects: A biomechanical, histological, and
radiographic analysis. J. Orthop. Res. 1996, 14, 351–369. [CrossRef] [PubMed]
22. Rueger, J.M.; Linhard, W.; Sommerfeldt, D. Biological reactions to calcium phosphate ceramic
implants—Results of animal experiments. Orthopäde 1998, 27, 89–95. [PubMed]
23. Klein, C.; Driessen, A.A.; Degroot, K.; Vandenhooff, A. Biodegradation behavior of various
calcium-phosphate materials in bone tissue. J. Biomed. Mater. Res. 1993, 17, 769–784. [CrossRef] [PubMed]
24. Jarcho, M. Calcium-phosphate ceramics as hard tissue prosthetics. Clin. Orthop. Rel. Res. 1981, 157, 259–278.
[CrossRef]
25. Le Huec, J.C.; Lesprit, E.; Delavigne, C.; Clement, D.; Chauveaux, D.; Le Rebeller, A. Tri-calcium phosphate
ceramics and allografts as bone substitutes for spinal fusion in idiopathic scoliosis as bone substitutes for
spinal fusion in idiopathic scoliosis: Comparative clinical results at four years. Acta Orthop. Belg. 1997,
63, 202–211. [PubMed]
26. Daculsi, G.; LeGeros, R.Z. Tricalcium phosphate/hydroxyapatite biphasic ceramics. In Bioceramics and Their
Clinical Applications; Kokubo, T., Ed.; CRC Press: Boca Raton, FL, USA, 2008; pp. 395–423.
27. Roy, D.M.; Linnehan, S.K. Hydroxyapatite formed from coral skeletal carbonate by hydrothermal exchange.
Nature 1974, 247, 220–222. [CrossRef] [PubMed]
28. Xu, Y.; Wang, D.; Yang, L.; Tang, H. Hydrothermal conversion of coral into hydroxyapatite. Mater. Charact.
2001, 47, 83–87. [CrossRef]
29. Vecchio, K.S.; Zhang, X.; Massie, J.B.; Wang, M.; Kim, C.W. Conversion of sea urchin spines to Mg-substituted
tricalcium phosphate for bone implants. Acta Biomater. 2007, 3, 785–793. [CrossRef] [PubMed]
30. Schlosser, M.; Fröls, S.; Hauf, U.; Sethmann, I.; Schultheiss, S.; Pfeifer, F.; Kleebe, H.-J. Combined
hydrothermal conversion and vapor transport sintering of Ag-modified calcium phosphate scaffolds. J. Am.
Ceram. Soc. 2013, 96, 412–419. [CrossRef]
31. Shors, E.C. Coralline bone graft substitutes. Orthop. Clin. N. Am. 1999, 30, 599–613. [CrossRef]
32. Pountos, I.; Giannoudis, P.V. Is there a role of coral bone substitutes in bone repair? Inj. Int. J. Care Inj. 2016,
47, 2606–2613. [CrossRef] [PubMed]
33. Boskey, A.L.; Posner, A.S. Effect of magnesium on lipid-induced calcification: An in vitro model for bone
mineralization. Calcif. Tissue Int. 1980, 32, 139–143. [CrossRef] [PubMed]
34. Yang, F.; Yang, D.; Tu, J.; Zheng, Q.; Cai, L.; Wang, L. Strontium enhances osteogenic differentiation of
mesenchymal stem cells and in vivo bone formation by activating WNT/catenin signalling. Stem Cells 2001,
29, 981–991. [CrossRef] [PubMed]
35. Marie, P.J. Optimizing bone matabolism in osteoporosis: Insight into the pharmacologic profile of strontium
ranelate. Osteoporos. Int. 2003, 14, S9–S12. [CrossRef] [PubMed]
J. Funct. Biomater. 2018, 9, 67 13 of 14
36. Barbara, A.; Delennoy, D.P.; Denis, B.G.; Marie, P.J. Normal matrix mineralization induced by strontium
ranelate in MC3T3-E1 osteogenic cells. Metabolism 2004, 53, 532–537. [CrossRef] [PubMed]
37. Kim, T.N.; Feng, Q.L.; Kim, J.O.; Wu, J.; Wang, H.; Chen, G.Q.; Cui, F.Z. Antimicrobial effects of metal ions
(Ag+, Cu2+, Zn2+) in hydroxyapatite. J. Mater. Sci.-Mater. Med. 1998, 9, 129–134. [CrossRef] [PubMed]
38. Liu, J.K.; Yang, X.H.; Tian, X.G. Preparation of silver/hydroxyapatite nanocomposite spheres. Powder Technol.
2008, 184, 21–24. [CrossRef]
39. Diaz, M.; Barba, F.; Miranda, M.; Guitian, F.; Torrecillas, R.; Moya, J.S. Synthesis and antimicrobial activity of
a silver-hydroxyapatite nanocomposite. J. Nanomater. 2009, 2009, 498505. [CrossRef]
40. Buckley, J.J.; Lee, A.F.; Olivi, L.; Wilson, K. Hydroxyapatite supported antibacterial Ag3PO4 nanoparticles.
J. Mater. Chem. 2010, 20, 8056–8063. [CrossRef]
41. Shirkhanzadeh, M.; Azadegan, M.; Liu, G.Q. Bioactive delivery systems for the slow-release of antibiotics:
Incorporation of Ag+ ions into micro-porous hydroxyapatite coatings. Mater. Lett. 1995, 24, 7–12. [CrossRef]
42. Feng, Q.L.; Kim, T.N.; Wu, J.; Park, E.S.; Kim, J.O.; Lim, D.Y.; Cui, F.Z. Antibacterial effects of Ag-HAp thin
films on alumina substrates. Thin Solid Films 1998, 335, 214–219. [CrossRef]
43. Chen, Y.K.; Zheng, X.B.; Xie, Y.T.; Ding, C.X.; Ruan, H.J.; Fan, C.Y. Anti-bacterial and cytotoxic properties of
plasma sprayed silver-containing HA coatings. J. Mater. Sci. Mater. Med. 2008, 19, 3603–3609. [CrossRef]
[PubMed]
44. Ando, Y.; Miyamoto, H.; Noda, I.; Sakurai, N.; Akiyama, T.; Yonekura, Y.; Shimazaki, T.; Miyazaki, M.;
Mawatari, M.; Hotokebuchi, T. Calcium phosphate coating containing silver shows high antibacterial activity
and low cytotoxicity and inhibits bacterial adhesion. Mater. Sci. Eng. C 2010, 30, 175–180. [CrossRef]
45. Bai, X.A.; More, K.; Rouleau, C.M.; Rabiei, A. Functionally graded hydroxyapatite coatings doped with
antibacterial components. Acta Biomater. 2010, 6, 2264–2273. [CrossRef] [PubMed]
46. Rameshbabu, N.; Kumar, T.S.S.; Prabhakar, T.G.; Sastry, V.S.; Murty, K.; Rao, K.P. Antibacterial nanosized
silver substituted hydroxyapatite: Synthesis and characterization. J. Biomed. Mater. Res. Part A 2007,
80A, 581–591. [CrossRef] [PubMed]
47. Nath, S.; Kalmodia, S.; Basu, B. Densification, phase stability and in vitro biocompatibility property of
hydroxyapatite-10 wt% silver composites. J. Mater. Sci. Mater. Med. 2010, 21, 1273–1287. [CrossRef]
[PubMed]
48. Zhang, Y.; Yin, Q.-S.; Zhang, Y.; Xia, H.; Ai, F.-Z.; Jiao, Y.-P.; Chen, X.-Q. Determination of antibacterial
properties and cytocompatibility of silver-loaded coral hydroxyapatite. J. Mater. Sci. Mater. Med. 2010,
21, 2453–2462. [CrossRef] [PubMed]
49. Matsumoto, N.; Sato, K.; Yoshida, K.; Hashimoto, K.; Toda, Y. Preparation and characterization of
beta-tricalcium phosphate co-doped with monovalent and divalent antibacterial metal ions. Acta Biomater.
2009, 5, 3157–3164. [CrossRef] [PubMed]
50. Gerber, L.C.; Mohn, D.; Fortunato, G.; Astasov-Frauenhoffer, M.; Imfeld, T.; Waltimo, T.; Zehnder, M.;
Stark, W.J. Incorporation of reactive silver-tricalcium phosphate nanoparticles into polyamide 6 allows
preparation of self-disinfecting fibers. Polym. Eng. Sci. 2011, 51, 71–77. [CrossRef]
51. Manjubala, I.; Sivakumar, M.; Kumar, T.S.S.; Rao, K.P. Synthesis and characterization of functional gradient
materials using Indian corals. J. Mater. Sci. Mater. Med. 2000, 11, 705–709. [CrossRef] [PubMed]
52. Manjubala, I.; Kumar, T.S.S. Effect of TiO2-Ag2O additives on the formation of calcium phosphate based
functionally graded bioceramics. Biomaterials 2000, 21, 1995–2002. [CrossRef]
53. Yamanaka, M.; Hara, K.; Kudo, J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by
energy-filtering transmission electron microscopy and proteomic analysis. Appl. Environ. Microbiol. 2005,
71, 7589–7593. [CrossRef] [PubMed]
54. Feng, Q.L.; Wu, J.; Chen, G.Q.; Cui, F.Z.; Kim, T.N.; Kim, J.O. A mechanistic study of the antibacterial effect of
silver ions on Escherichia coli and Staphylococcus aureus. J. Biomed. Mater. Res. 2000, 52, 662–668. [CrossRef]
55. Jones, J.R.; Ehrenfried, L.M.; Saravanavan, P.; Hench, L.L. Controlling ion release from bioactive glass foam
scaffolds with antibacterial properties. J. Mater. Sci. Mater. Med. 2006, 17, 989–996. [CrossRef] [PubMed]
56. Fox, C.L.; Modak, S.M. Mechanism of silver sulfadiazine action on burn wound infections.
Antimicrob. Agents Chemother. 1974, 5, 582–588. [CrossRef] [PubMed]
57. Choi, O.; Deng, K.K.; Kim, N.J.; Ross, L.; Surampalli, R.Y.; Hu, Z.Q. The inhibitory effects of silver
nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res. 2008, 42, 3066–3074.
[CrossRef] [PubMed]
J. Funct. Biomater. 2018, 9, 67 14 of 14
58. Sethmann, I.; Luft, C.; Kleebe, H.-J. Development of phosphatized calcium carbonate biominerals as bioactive
bone graft substitute materials, part I: Incorporation of magnesium and strontium ions. J. Funct. Biomater.
2018. submitted.
59. Bigi, A.; Foresti, E.; Gandolfi, M.; Gazzano, M.; Roveri, N. Isomorphous substitutions in β-tricalcium
phosphate: The different effects of zinc and strontium. J. Inorg. Biochem. 1997, 66, 259–265. [CrossRef]
60. Gustafsson, J.P. Visual MINTEQ, version 3.1; KTH, SEED: Stockholm, Sweden, 2016.
61. Tsipouras, N.; Rix, C.J.; Brady, P.H. Solubility of silver sulfadiazine in physiological media and relevance to
treatment of thermal burns with silver sulfadiazine cream. Clin. Chem. 1995, 41, 87–91. [PubMed]
62. Nikaido, H.; Nakae, T. The outer membrane of Gram-negative bacteria. Adv. Microb. Physiol. 1980,
20, 163–250.
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
